Anisa Mohanty | The National Law Review
Anisa Mohanty advises life sciences companies on regulatory, compliance, enforcement, policy, and legislative matters arising under the Federal Food, Drug, and Cosmetic Act.
Stay updated with breaking news from Quality System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anisa Mohanty advises life sciences companies on regulatory, compliance, enforcement, policy, and legislative matters arising under the Federal Food, Drug, and Cosmetic Act.
Vernessa Pollard is a pharmaceutical lawyer with McDermott Law, she advises companies on regulatory, compliance and enforcement matters involving pharmaceuticals.
Anisa Mohanty advises life sciences companies on regulatory, compliance, enforcement, policy, and legislative matters arising under the Federal Food, Drug, and Cosmetic Act.
This week, HHS issued more than $560 million in PRF Phase 4 General Distribution payments and CMS announced the ACO Realizing Equity, Access, and Community Health (REACH) Model.
FDA proposed amendments to the CGMP requirements of the Quality System (QS) Regulation will align them more closely with the international consensus standard for devices.